skip to Main Content
large burst
light ray
upper burst
square

Unlock the
power of proteins

Apply our revolutionary CodeEvolver® platform technology to deliver high-performing enzymes and customized solutions in a wide array of applications.

Watch the video
blue-dna

Pharmaceuticals

Improve production processes with state-of-the-art enzymes.

Learn More

adam-staring-at-petri-dish

Biotherapeutics

Create novel therapeutic proteins with highly optimized performance.

Learn More

Sugar_enzyme

Food & Beverage

Impact product quality and profitability with expert protein engineering.

Learn More

molecular-diagnostics-thumb

Molecular Diagnostics

Accelerate next-generation sequencing with powerful enzyme solutions.

Learn More

blockquote

“The partnership with Codexis strengthens our footprint in the enzyme field, a fast-developing part of the nutritional therapy innovation frontier that is changing the way we manage our health.”

Greg Behar, CEO
Nestlé Health Science

“We chose the Codexis platform after a thorough evaluation of the enzyme evolution landscape. Codexis has a significant track record of delivering evolved biocatalysts for pharmaceutical and fine chemical applications over an extended period of time.”

Doug Fuerst, Technology Development Lead, Synthetic Biology
GlaxoSmithKline

“We view Codexis as an extension of our internal research and development programs at Tate & Lyle and are excited about the opportunities which this partnership brings to deliver new and innovative food ingredients to the market.”

Michael Harrison, Senior Vice President of New Product Development
Tate & Lyle

“[Codexis’] process, which won a 2010 Presidential Green Chemistry Award, increased sitagliptin yield, cut back on production steps, and reduced water use and waste. The advance led to a threefold increase in productivity and helped us avoid the cost of building a second factory to meet rising demand for Januvia.”

R.P. "Skip" Volante, Vice President of R&D
Merck

Latest News

29May 18

Codexis to Present at Three Upcoming Investment Conferences

REDWOOD CITY, Calif. , May 29, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: 15 th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 30 ,…
read more
10May 18

Codexis Reports First Quarter 2018 Financial Results

Total revenues increase 76% to $14.0 million on sharply higher R&D revenue Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , May 10, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces…
read more
23Apr 18

Porton Pharma Solutions and Codexis Launch Global Partnership

View translation: Japanese | Simplified Chinese | Traditional Chinese Redwood City, Calif., and Chongqing, China (April 23, 2018) – Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology…
read more
Back To Top
Close search
Search